118 related articles for article (PubMed ID: 38576381)
1. NCAPD3 is a prognostic biomarker and is correlated with immune infiltrates in glioma.
Qu L; Che H; Zhao J; Lu X; Ren Z; Wu Y; Liu Q; Guan H
Histol Histopathol; 2024 Mar; ():18736. PubMed ID: 38576381
[TBL] [Abstract][Full Text] [Related]
2. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma.
Ma W; Mei P
World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
[TBL] [Abstract][Full Text] [Related]
3. Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation
Yuan CW; Sun XL; Qiao LC; Xu HX; Zhu P; Chen HJ; Yang BL
World J Gastroenterol; 2019 Dec; 25(47):6813-6822. PubMed ID: 31885422
[TBL] [Abstract][Full Text] [Related]
4. CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma.
Wang F; Zhao F; Zhang L; Xiong L; Mao Q; Liu Y; Qiu X; Wang X; Shui L; Chen X; Ren K; Shui P; Zhang Q; Deng Y; Li W; Xie X; Wu D; Li T; Lang J; Liu L; Chen H; Xu J; Bai S; Li Z; Yue Q; Chen N; Zhou B; Yi C; Wei Y; Fu Y; Luo Y; Gou Q; Liu L; Liu Y; Kang J; Wang J; Jing D; Zhang F; Yang X; Li X; Jiang T; Zhang Z; Zhou Y; Yi J
Mol Cancer; 2022 Jul; 21(1):153. PubMed ID: 35879762
[TBL] [Abstract][Full Text] [Related]
5. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
[TBL] [Abstract][Full Text] [Related]
6. CNPY4 is a potential promising prognostic-related biomarker and correlated with immune infiltrates in gliomas.
Li JW; Huang QR; Mo LG
Medicine (Baltimore); 2022 Aug; 101(33):e30044. PubMed ID: 35984129
[TBL] [Abstract][Full Text] [Related]
7.
Ge X; Xu M; Cheng T; Hu N; Sun P; Lu B; Wang Z; Li J
Front Immunol; 2022; 13():974346. PubMed ID: 36275718
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma.
Tao BY; Liu YY; Liu HY; Zhang ZH; Guan YQ; Wang H; Shi Y; Zhang J
Front Genet; 2022; 13():852049. PubMed ID: 35591854
[No Abstract] [Full Text] [Related]
9. NCAPG as a Novel Prognostic Biomarker in Glioma.
Jiang X; Shi Y; Chen X; Xu H; Liu B; Zhou F; Huang X; Cho WC; Li L; Pu J
Front Oncol; 2022; 12():831438. PubMed ID: 35280743
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q
Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194
[No Abstract] [Full Text] [Related]
11. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
12. A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.
Xu J; Liu F; Li Y; Shen L
Cell Mol Neurobiol; 2022 Apr; 42(3):709-722. PubMed ID: 32894375
[TBL] [Abstract][Full Text] [Related]
13. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma.
Qiu H; Tian W; He Y; Li J; He C; Li Y; Liu N; Li J
Front Oncol; 2021; 11():654350. PubMed ID: 33954112
[TBL] [Abstract][Full Text] [Related]
14. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of the prognostic value of NEK8 and its effects on immune cell infiltration in glioma.
Xiao M; Du C; Zhang C; Zhang X; Li S; Zhang D; Jia W
J Cell Mol Med; 2021 Sep; 25(18):8748-8763. PubMed ID: 34374193
[TBL] [Abstract][Full Text] [Related]
16. HAUS Augmin-Like Complex Subunit 1 Influences Tumour Microenvironment and Prognostic Outcomes in Glioma.
Yao Q; Ge X; Lu Z; Shi J; Shen J; Chen J
J Oncol; 2022; 2022():8027686. PubMed ID: 35865089
[TBL] [Abstract][Full Text] [Related]
17. NCAPD3 exerts tumor-promoting effects in prostatic cancer via dual impact on miR-30a-5p by STAT3-MALAT1 and MYC.
Zhang Y; Shao Y; Ren J; Fang Y; Yang B; Lu S; Liu P
Cell Death Discov; 2024 Apr; 10(1):159. PubMed ID: 38561330
[TBL] [Abstract][Full Text] [Related]
18. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.
Jing Z; Liu Q; He X; Jia Z; Xu Z; Yang B; Liu P
J Exp Clin Cancer Res; 2022 Jun; 41(1):198. PubMed ID: 35689245
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma.
Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z
Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479
[TBL] [Abstract][Full Text] [Related]
20. Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion.
Li G; Huang R; Fan W; Wang D; Wu F; Zeng F; Yu M; Zhai Y; Chang Y; Pan C; Jiang T; Yan W; Wang H; Zhang W
Front Immunol; 2021; 12():800928. PubMed ID: 34956239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
